Alseres Financial Statements From 2010 to 2026

Alseres Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Alseres Pharmaceuticals' valuation are provided below:
Alseres Pharmaceuticals does not presently have any fundamental signals for analysis.
Check Alseres Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alseres Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Alseres financial statements analysis is a perfect complement when working with Alseres Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Alseres Pharmaceuticals Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Alseres Pharmaceuticals Company Shares Outstanding Analysis

Alseres Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Alseres Pharmaceuticals Shares Outstanding

    
  6.13 K  
Most of Alseres Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alseres Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Alseres Pharmaceuticals has 6.13 K of shares currently outstending. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 100.0% higher than that of the company.

Alseres Pharmaceuticals Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alseres Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Alseres Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alseres Pharmaceuticals competition to find correlations between indicators driving Alseres Pharmaceuticals's intrinsic value. More Info.
Alseres Pharmaceuticals is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alseres Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Alseres Pink Sheet

If you are still planning to invest in Alseres Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alseres Pharmaceuticals' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio